Search tips
Search criteria 


Logo of cviPermissionsJournals.ASM.orgJournalAEM ArticleJournal InfoAuthorsReviewers
Clin Vaccine Immunol. 2010 December; 17(12): 1933–1939.
Published online 2010 October 6. doi:  10.1128/CVI.00404-10
PMCID: PMC3008182

Molecular Cloning of an Immunogenic Protein of Baylisascaris procyonis and Expression in Escherichia coli for Use in Developing Improved Serodiagnostic Assays[down-pointing small open triangle]


Larva migrans caused by Baylisascaris procyonis is an important zoonotic disease. Current serological diagnostic assays for this disease depend on the use of the parasite's larval excretory-secretory (ES) antigens. In order to identify genes encoding ES antigens and to generate recombinant antigens for use in diagnostic assays, construction and immunoscreening of a B. procyonis third-stage larva cDNA expression library was performed and resulted in identification of a partial-length cDNA clone encoding an ES antigen, designated repeat antigen 1 (RAG1). The full-length rag1 cDNA contained a 753-bp open reading frame that encoded a protein of 250 amino acids with 12 tandem repeats of a 12-amino-acid long sequence. The rag1 genomic DNA revealed a single intron of 837 bp that separated the 753-bp coding sequence into two exons delimited by canonical splice sites. No nucleotide or amino acid sequences present in the GenBank databases had significant similarity with those of RAG1. We have cloned, expressed, and purified the recombinant RAG1 (rRAG1) and analyzed its diagnostic potential by enzyme-linked immunosorbent assay. Anti-Baylisascaris species-specific rabbit serum showed strong reactivity to rRAG1, while only minimal to no reactivity was observed with sera against the related ascarids Toxocara canis and Ascaris suum, strongly suggesting the specificity of rRAG1. On the basis of these results, the identified RAG1 appears to be a promising diagnostic antigen for the development of serological assays for specific detection of B. procyonis larva migrans.

In North America, Europe, and parts of Asia, the raccoon roundworm, Baylisascaris procyonis, is responsible for neural larva migrans (NLM) in more than 100 mammal and bird species, including humans (17). Infection occurs upon accidental ingestion of embryonated B. procyonis eggs from environmental areas or articles contaminated with raccoon feces (17, 26). During the years from 1975 to 2009, 18 cases of B. procyonis larva migrans in children were reported from the United States and Canada, where raccoons are common (4, 13, 24, 27). In addition to causing NLM, the parasite is also a well-known cause of visceral and ocular larva migrans, being considered the primary cause of the large nematode variant of diffuse unilateral subacute neuroretinitis (DUSN) (11, 17). In most patients, NLM caused by heavy infection with B. procyonis has resulted in either death or permanent neurological deficits (24). The diagnosis of B. procyonis NLM is currently based on clinical symptoms, laboratory findings, and epidemiological investigation, along with corroborating evidence of reactivity of a suspected patient's serum to B. procyonis excretory-secretory (BPES) antigens in an indirect enzyme-linked immunosorbent assay (ELISA) (6, 13, 29). Cases with clinical improvement (4, 13) or apparent recovery (27) following proper diagnosis and aggressive treatment have been documented more recently.

Excretory-secretory antigens of helminth parasites are widely used in serological assays, such as ELISA, Western blotting, and multi-immunodot assays, for the diagnosis of parasitic infections in humans (8, 12, 14, 23, 32). Our laboratory currently utilizes BPES antigens in ELISA to test for antibodies in patients suspected of having B. procyonis NLM. The test has been a very useful aid in the diagnosis of this infection, especially in children (6, 29). However, antibodies to Toxocara spp. cross-react with BPES antigens and thus reduce the specificity of BPES antigen-based ELISA (7). Recently, we have reported that more specific diagnosis of this infection can be made using Western blot assays, with specific recognition of 30- to 45-kDa proteins of BPES antigen by serum from patients with B. procyonis larva migrans (7).

Apart from the cross-reactivity factor, the production of ES antigens is cumbersome and time-consuming, is dependent on the availability of B. procyonis eggs, and involves the handling of infective eggs and larvae. Identification of Baylisascaris species-specific immunogenic proteins can facilitate the production of recombinant antigens, which can be easily purified and which could have increased specificity compared to ES antigens. To date, none of the antigens of the BPES antigen complex have been characterized and no genetic information about B. procyonis ES antigens is available.

In this study, in order to identify genes encoding immunodominant ES antigens, we performed immunoscreening of a B. procyonis third-stage larva (L3) cDNA expression library using anti-B. procyonis baboon sera. We identified and characterized the gene encoding an ES protein, designated repeat antigen 1 (RAG1), the cDNA of which was expressed in Escherichia coli. In ELISA, the recombinant RAG1 (rRAG1) showed highly specific reactivity with antibodies to Baylisascaris spp. and did not cross-react with antibodies to the related ascarids Toxocara canis and Ascaris suum.


B. procyonis, Ascaris suum, and Toxocara canis larval ES antigen preparation.

Fertile B. procyonis eggs were collected and embryonated in 2% (vol/vol) formalin-0.85% (wt/vol) saline (18), and in vitro culture of hatched larvae was carried out as described previously (2) with slight modifications also described previously (7). Briefly, the culture medium containing the ES antigens of B. procyonis larvae was collected at weekly intervals and dialyzed against 0.1 M ammonium bicarbonate solution, and the ES antigens were concentrated by lyophilization. The protein concentration of the ES antigen was estimated using a bicinchoninic acid protein assay kit (Pierce/Thermo Fisher Scientific, Asheville, NC), and aliquots of the ES antigen were prepared and stored at −20°C until use. ES antigens from A. suum and Toxocara canis were available in our laboratory from a previous study (3) and were used in Western blot assays to determine the reactivity of anti-rRAG1 mouse antibodies to these antigens.

Anti-B. procyonis baboon serum and positive- and negative-control sera.

Anti-B. procyonis serum used for immunoscreening of the B. procyonis L3 cDNA expression library was obtained from the Division of Parasitic Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA. The serum was from a baboon that developed severe NLM after experimental infection with B. procyonis embryonated eggs. This anti-B. procyonis baboon serum was also used as positive-control serum in serological assays. Serum from a healthy adult human with no history of exposure to raccoons or any clinical signs of larva migrans was used as the negative control. Prior to use for immunoscreening, the baboon serum was extensively adsorbed with E. coli XL1-Blue MRF′ cell lysates, to deplete it of antibodies to the bacterial proteins (30).

SDS-PAGE and Western blotting.

B. procyonis ES antigens and rRAG1 were analyzed by SDS-PAGE under reducing conditions and Western blotting by standard procedures (20, 33). Western blotting was performed by probing the antigen on nitrocellulose paper (NCP) with primary antibody (anti-B. procyonis baboon serum and/or anti-rRAG1 mouse serum) at a 1-in-100 dilution and the respective secondary antibody, either horseradish peroxidase (HRP)-conjugated affinity-purified goat anti-human IgG (H+L) (Jackson Immunoresearch Laboratories, Inc., West Grove, PA) or HRP-conjugated anti-mouse IgG. Chromogenic substrate, tetramethylbenzidine (TMB; Thermo Scientific, Rockford, IL), was used to develop the Western blots.

Construction and immunoscreening of B. procyonis L3 cDNA expression library.

B. procyonis L3 from 1-week-old in vitro cultures were used for RNA extraction using the Trizol reagent (Invitrogen Corporation, Carlsbad, CA). The cDNA was synthesized using a ZAP-cDNA synthesis kit (Stratagene, La Jolla, CA) and cloned into bacteriophage lambda ZAP II vector digested with EcoRI and XhoI (Uni-ZAP XR vector; Stratagene) according to the manufacturer's suggested procedures. The titer of the library was determined to be 1.45 × 109 PFU ml−1 and to have 94% recombinant phages and with 3/4 of the inserts being either 500 bp or greater in length. Immunoscreening of this expression library was performed to identify recombinant phages expressing B. procyonis antigens. Dilutions of the cDNA library were prepared to plate approximately 500 to 1,000 PFU of recombinant phages onto NZY agar (Amresco, Solon, OH) in a 150-by-15-mm petri dish. Recombinant plaques expressing B. procyonis antigens were identified by transferring the plaques onto NCP and processing as Western blots. Anti-B. procyonis baboon serum (1-in-100 dilution) free of antibodies to E. coli antigens was used as the primary antibody, HRP-conjugated goat anti-human IgG (H+L) (Jackson Immunoresearch Laboratories, Inc.) was used as the secondary antibody, and TMB was used as the substrate. The corresponding plaques were cored out of the agar plate and plaque purified at least twice to obtain a homogenous population of the recombinant phage.

Preparation of RAG1 antigen-selected monospecific antibodies.

Affinity purification of antibodies specific to RAG1 (expressed by the selected phage Bp1) was performed using NCP. The plaque-purified recombinant phages were plated on NZY agar plates and incubated at 37°C. When the plaques became visible, antigens from the recombinant phages were transferred onto both sides of the NCP and the NCP was carefully removed from the agar plate, washed with TBS, and blocked in 5% skim milk prepared in Tris-buffered saline (TBS). This NCP was then incubated in anti-B. procyonis baboon serum (1-in-100 dilution) at 4°C overnight. After thorough washing of the NCP with TBS containing 0.25% Tween 20, antibodies bound to the RAG1 antigen expressed by the phage were eluted by incubating the NCP in 0.2 M glycine buffer, pH 2.8, and neutralized to pH 7.0 immediately by adding 1.32 M Tris. The eluted RAG1-monospecific antibodies were used to perform Western blots with BPES antigens to identify the reactive native RAG1.

Sequence analysis of rag1 cDNA and genomic DNA.

The single-stranded pBluescript phagemid within the lambda phage carrying the B. procyonis rag1 cDNA insert was rescued using a rapid excision kit (Stratagene) and sequenced to determine the nucleotide sequence of the rag1 cDNA insert. The 5′ region of this partial rag1 cDNA was identified by performing 5′ RNA ligase-mediated rapid amplification of the cDNA ends (5′ RLM-RACE) using a FirstChoice RLM RACE kit (Ambion Inc., Austin, TX). Briefly, 5′ RACE adapter-tagged B. procyonis cDNA was synthesized from 10 μg of B. procyonis L3 total RNA and used as the template in a PCR with a 5′ RACE adapter-specific outer primer (5′-GCTGATGGCGATGAATGAACACTG-3′) and rag1 gene-specific primer rag1GSP (5′-ATCTGCTGCGTCACTTCTTGCCACA-3′) to amplify the unknown 5′ region of rag1 cDNA.

The full-length gene of rag1 from the genomic DNA of the parasite was obtained via PCR using a pair of custom-designed primers. The forward primer rag1FLF (5′-AGATCTTTCGTTTCTCACAATTGGCA-3′) was designed on the basis of the sequence obtained from the 5′ RLM-RACE reaction, and the reverse primer rag1FLR (5′-CCATGGTTATTGCTGTGCACAGA-3′) was based on the sequence of the rag1 cDNA insert obtained from immunoscreening of the B. procyonis L3 cDNA expression library. Products of the RACE PCR and those from the amplification of the rag1 gene from genomic DNA were cloned and sequenced to ascertain the sequence of the 5′ region of rag1 cDNA and the full-length gene. All sequencing reactions were performed by Purdue University's Core Sequencing Facility.

Cloning, expression, and purification of rRAG1 and generation of anti-rRAG1 mouse antibodies.

The partial rag1 cDNA identified from the library was amplified by PCR using the primers rag1F and rag1R (5′-AGATCTTCTCGGCACGAGGA-3′ and 5′-CCATGGTTATTGCTGTGCACAGA-3′, respectively) and subcloned into BglII- and NcoI-digested pRSETC (Invitrogen) expression vector. BL21(DE3)/pLysS E. coli competent cells (Invitrogen) were transformed with the pRSETC/rag1 plasmid and the recombinant colonies were selected. Overexpression of rRAG1 was achieved at 4 h after 0.5 mM isopropyl-β-d-thiogalactopyranoside induction at 37°C. Overexpression of rRAG1 was confirmed by SDS-PAGE and by performing Western blot analysis using anti-Xpress antibodies (Invitrogen) and anti-B. procyonis baboon sera.

Purification of this polyhistidine-tagged rRAG1 fusion protein was achieved under denaturing conditions, according to the manufacturer's instructions, using Talon superflow metal affinity resins (Clontech, Inc., Mountain View, CA). Briefly, a pH-based purification protocol was used, with all buffers containing 6 M urea as the denaturing agent. The purified protein fractions were extensively dialyzed against phosphate-buffered saline at 4°C, aliquoted, and stored at −80°C until use. Antibodies to the purified rRAG1 raised in BALB/c mice were used to identify the native RAG1 in the BPES antigen complex. Preimmunization serum was used as a negative control.

Enzyme-linked immunosorbent assay with rRAG1.

Serum samples from rabbits (New Zealand White) experimentally infected with embryonated eggs of different Baylisascaris spp. (B. procyonis, B. transfuga, B. columnaris, and B. melis) and related ascarids (A. suum and T. canis) were available in our laboratory from previous studies (2). Preinfection serum and serum from the final bleeding postinfection from each of these rabbits were used in ELISA. Any antibodies to E. coli antigens present in the serum samples were adsorbed prior to application of the serum in ELISA by incubating the serum samples with E. coli cell lysate for 1 h at room temperature.

ELISA with rRAG1 was performed in Immulon2HB (Thermo Scientific, Asheville, North Carolina) flat-bottom microtiter plates. The wells were coated with 0.125 μg of rRAG1 per well, and the plates were incubated at 4°C overnight. Primary antibody (rabbit serum samples) at three different dilutions (1 in 50, 100, and 200) and secondary antibody (HRP-conjugated goat anti-rabbit IgG [H+L] [Jackson Immunoresearch Laboratories, Inc.]) at a 1-in-5,000 dilution were used. ortho-Phenylenediamine (Sigma-Aldrich) at a concentration of 1 mg/ml was used as the substrate. The enzyme reaction was stopped with 3 N HCl, and the optical density (OD) of the developed color was measured at 450 nm using a SpectraMax absorbance microplate reader (Molecular Devices, Sunnyvale, CA).

Nucleotide sequence accession numbers.

The 877-bp full-length rag1 cDNA and the 1,610-bp-long amplicon were submitted to GenBank and can be found under accession numbers GU811847 and GU811848, respectively.


Identification and nucleotide sequence determination of a cDNA encoding RAG1.

Several immunoreactive recombinant phages were identified upon screening of the B. procyonis L3 cDNA expression library with anti-B. procyonis baboon serum. One of the strongly reactive plaques, Bp1, was selected and analyzed further. Western blot analysis with the monospecific antibodies against this recombinant phage showed strong reactivity to several components (molecular masses, 52 kDa and higher) of the B. procyonis ES antigen (Fig. (Fig.1).1). Nucleotide sequencing of recombinant phage Bp1 revealed an 845-bp B. procyonis cDNA insert, designated rag1. The deduced amino acid sequence analysis indicated an open reading frame (ORF) of 741 bp (partial 5′ end) that encoded a 246-amino-acid-long polypeptide, RAG1. A 104-bp untranslated region (UTR) and a poly(A) tail were present at the 3′ end downstream of the stop codon. No start codon was detected at the 5′ end.

FIG. 1.
Western blot reactivity of RAG1-monospecific antibodies to Baylisascaris procyonis excretory-secretory antigen. Monospecific antibodies against RAG1 expressed by the recombinant phage Bp1 showed strong reactivity to Baylisascaris excretory-secretory components ...

Sequence analysis of full-length rag1 cDNA and genomic DNA.

Sequence analysis of the 5′ RACE PCR-amplified product allowed us to extend the 5′ end of rag1 cDNA by 32 bp and to identify a putative translation initiation codon, which resulted in a combined full-length rag1 cDNA of 877 bp (GenBank accession no. GU811847). Thus, the rag1 cDNA has a 753-bp-long ORF flanked by 5′ and 3′ UTRs of 20 and 104 bp, respectively (Fig. 2A and B). The 753-bp ORF is capable of encoding a protein of 250 amino acids with a predicted molecular mass of approximately 25 kDa (which excludes the signal peptide) (Fig. (Fig.2B).2B). The deduced amino acid sequence of this protein is characterized by an N-terminal region spanning 12 tandemly arrayed amino acid repeats consisting of a 12-amino-acid-long invariable sequence (PPAGNQMQGGAN). Corresponding to the amino acid repeats, the nucleotide sequence of the rag1 cDNA also contained 12 direct repeats of a 36-bp-long sequence. However, the nucleotide sequences of the repeats showed a significant variation in codon usage, suggesting the existence of a selective pressure maintaining the constant amino acid sequence of the repeats. Analysis of the amino acid sequence using the simple modular architecture research tool (SMART) (31) predicted a signal peptide between amino acids 1 and 21 and two copies of cysteine-rich potassium channel-blocking toxin (ShKT) domain at the C terminus of the protein (positions 176 to 212 and 213 to 248) (Fig. (Fig.2B).2B). The ShKT domain is also referred to as the NC6 or SXC motif in several nematode proteins and has a consensus sequence pattern XCXDX4-6CX4-8CX12CX2TCX2C (10). Multiple potential O-glycosylation sites in the two ShKT domains were predicted using the NetOGlyc program (version 3.1) (15). Blastn (nucleotide-nucleotide BLAST) (35) searches of the GenBank databases did not reveal any nucleotide sequences with significant similarity to rag1. Blastp analysis with the deduced amino acid sequences showed limited similarity to the sequences of different proteins with repeats rich in proline, glycine, glutamine, and asparagine from multiple organisms.

FIG. 2.
(A) Schematic representation of the organization of Baylisascaris procyonis full-length rag1 cDNA and genomic DNA. (B) Full-length nucleotide sequence of Baylisascaris procyonis rag1 cDNA and the deduced amino acid sequence. The sequence of the signal ...

The rag1 gene was PCR amplified from the parasite's genomic DNA using the oligonucleotides rag1FLF and rag1FLR. Alignment of the 1,610-bp-long amplicon (GenBank accession no. GU811848) revealed that the 753-bp ORF was separated by one 837-bp-long intron delimited by the canonical splice sites, as determined by the alternate splice site predictor program (ASSP at

Cloning, expression, purification, and reactivity of rRAG1.

The rag1 cDNA insert in the pRSETC expression vector was smaller (615 bp) than the original cloned amplicon (663 bp, which includes all the repeats), and sequence analysis revealed a loss of nucleotide sequences in the repeat region (positions 215 to 359; Fig. Fig.2B),2B), resulting in only 8 repeats in the cloned rag1 cDNA insert. However, the amino acid sequence of the repeats was preserved and did not hinder the expression of rRAG1. This expression clone encoded a protein consisting of a total of 250 amino acids (204 amino acids coded by the rag1 cDNA and 46 amino acids for the vector) and had a predicted molecular mass of approximately 26.1 kDa. However, when analyzed on a 12% SDS-polyacrylamide gel, the protein migrated as an ~35-kDa protein.

Western blots performed by probing the purified rRAG1 with anti-Xpress antibody and anti-B. procyonis baboon sera showed strong reactivity to the 35-kDa rRAG1 (Fig. (Fig.33).

FIG. 3.
Western blots showing the reactivity of anti-B. procyonis baboon serum (A) and anti-Xpress antibody (B) to rRAG1 protein. Both anti-B. procyonis baboon serum and anti-Xpress antibodies reacted to the 35-kDa rRAG1 protein in the postinduction fraction ...

Diagnostic potential of rRAG1 protein.

Anti-rRAG1 mouse antibodies showed a strong reactivity to rRAG1 in Western blot analysis. The antibodies also reacted with BPES antigenic components of several sizes at ~37 kDa and some above 57 kDa in size, making it difficult to identify the native RAG1 (Fig. (Fig.4).4). Fortunately, the anti-rRAG1 antibodies did not recognize any component of the ES antigens of A. suum or T. canis (data not shown), suggesting the absence of cross-reactive epitopes in the ES antigens of the two ascarids evolutionarily related to B. procyonis. To further evaluate the specificity, an ELISA based on rRAG1 was standardized and the results were compared with those of the BPES ELISA. Serum from rabbits experimentally infected with either B. procyonis, B. columnaris, B. melis, or B. transfuga showed strong reactivity with rRAG1 in ELISA at all three dilutions, although the anti-B. transfuga serum reaction was weaker than the others (Fig. (Fig.5A).5A). In ELISA with BPES antigen serum from all rabbits infected with Baylisascaris spp., including those infected with B. transfuga, showed a similar strong reaction (Fig. (Fig.5B).5B). While the anti-T. canis and anti-A. suum rabbit sera showed strong reactions in the BPES antigen-based ELISA (Fig. (Fig.5B),5B), these serum samples did not react with the rRAG1 antigen and had OD values similar to those of the preinfection serum samples (Fig. (Fig.5A5A).

FIG. 4.
Western blots showing the reactivities of anti-B. procyonis and anti-rRAG1 mouse antibodies to BPES antigens and rRAG1. The anti-rRAG1 mouse antibodies reacted to several components of the B. procyonis excretory-secretory antigen at 37 kDa and other higher-molecular-mass ...
FIG. 5.
(A and B) Reactivity of serum from rabbits (at three dilutions) infected with different ascarids on Baylisascaris procyonis rRAG1 (A) and excretory-secretory antigen-based (B) enzyme linked immunosorbent assays. In the rRAG1 ELISA, strong reactivity is ...


The currently available ES antigen-based ELISA for serological detection of B. procyonis larva migrans exhibits low specificity, primarily because of antigenic cross-reactivity with related ascarids (such as T. canis and A. suum) (3) resulting from potentially conserved proteins, a phenomenon well documented in other parasites (9, 28). Despite this, ES antigens are widely used in serological assays in either crude or purified (native or recombinant) form to diagnose parasite infections (23, 32, 34), and recombinant antigen-based serological assays show increased diagnostic specificity (23, 34). However, production of recombinant proteins requires knowledge about the genes encoding the specific antigens. The present study was undertaken to identify genes that code for BPES antigens. To the best of our knowledge, this is the first report of molecular cloning and expression of an antigenic protein of Baylisascaris procyonis.

In the absence of posttranslational modifications, native RAG1 can be expected to have a molecular mass of about 25 kDa, on the basis of full-length rag1 cDNA (assuming that the signal peptide is cleaved and all 12 repeats are present). However, the presence of multiple cysteines favoring protein-protein interaction and potential sites of glycosylation can result in a protein with a higher molecular mass. In addition, rRAG1 migrated slowly in polyacrylamide gels and showed an unexpected apparent mass, possibly due to the rigidity conferred by proline in polypeptides. This has been documented in proline-rich proteins from different organisms (19, 25). The identification of the native RAG1 antigen was not possible because both monospecific and anti-rRAG1 antibodies reacted with multiple proteins (52 kDa and higher) in the BPES antigen. However, the anti-rRAG1 antibodies alone reacted to an ~37-kDa protein in the BPES antigens, suggesting that this protein could be the native RAG1; further studies are needed to confirm the actual molecular size of the native RAG1. Although blastn analysis did not show any significant identity of the protein sequence to any known parasite nucleotide sequences, the blastp analysis showed that it has limited similarity to different proteins with repeats rich in proline, glycine, glutamine, and asparagine such as the S antigen and phosphatidylcholine-sterol acyltransferase from Plasmodium falciparum and a hypothetical protein from Branchyostoma floridae. Therefore, an identity could not be assigned to RAG1. However, on the basis of the reactivity of monospecific and anti-rRAG1 mouse antibodies to several components of the BPES antigen complex, reactivity of the antibodies to proteins transcribed from a multigene family cannot be ruled out and requires further investigation. In addition to the repeats, rRAG1 contains two tandemly located cystiene-rich motifs at the C terminus, which has been described in several nematodes, including Toxocara canis and Caenorhabditis elegans (1, 22). This domain has been cited under different names (ShkT domain/NC6 motif/SXC motif) but is commonly recognized as the SXC motif in nematodes. The SXC motif homology arises only by virtue of the position of the six cysteine residues and not other amino acids. Scientific literature shows that the SXC motif has largely been associated with the functional domain of diverse proteins, viz., phosphatidylethanolamine-binding protein, zinc metalloprotease, tyrosinases, lectins, mucins, etc. The domain is also known to associate with signal peptides or in an extracellular milieu facilitates protein-protein interaction (22). Initially identified in T. canis, the SXC motif has been identified in several other nematode parasites, including A. suum, Brugia spp., Trichuris spp., and Necator americanus. In addition, no homology to the 12-mer amino acid repeat could be identified, and therefore, a putative function of this protein is not known. At the least, the presence of a secretory signal and the reactivity of RAG1-monospecific and anti-rRAG1 mouse antibodies to components of BPES antigen suggest that RAG1 is a component of the ES antigen. Excretory-secretory antigens in parasites serve several functions, such as in feeding, penetration of the host, tissue migration, reproduction, and immune evasion (5, 16, 21). Functional assays are required to determine the function of this protein in B. procyonis. Also, the rag1 cDNA described here has been identified from B. procyonis L3, a tissue migration stage of the parasite in the paratenic host and also the parasite stage seen in larva migrans. Whether the expression of this gene is parasite stage specific is not known.

Anti-rRAG1 mouse antibodies did not recognize any proteins in A. suum or T. canis ES antigens, suggesting the absence of RAG1 homologues or cross-reactive epitopes in the ES antigens of A. suum and T. canis. The antibodies raised against rRAG1 strongly reacted to a similar group of BPES antigens (37 to 52 kDa), further supporting the idea of these proteins being specific to B. procyonis. The absence of cross-reactivity of this protein in ELISA to serum raised against related ascarids like Toxocara and Ascaris also suggests that this protein might be unique to Baylisascaris spp. Among the Baylisascaris spp., strong reactivity was observed with serum against B. procyonis, B. columnaris, and B. melis. These parasites are closely related and are considered to be highly pathogenic causes of larva migrans compared to the somewhat distantly related and less pathogenic species B. transfuga. The anti-B. transfuga serum did not react as strongly as serum against other Baylisascaris spp. The presence of the RAG1 gene in related parasites remains to be investigated.

The B. procyonis RAG1 reported here is a potential diagnostic antigen that appears to be highly specific for Baylisascaris spp. and that does not cross-react with antibodies to either Toxocara canis or Ascaris suum, two common ascarid parasites to which humans may also be exposed. Ongoing studies in our laboratory using this rRAG1 protein for the diagnosis of B. procyonis larva migrans in humans by ELISA also suggest that there is no cross-reactivity with antibodies to Toxocara canis or other parasites. This recombinant antigen should be useful in various assay formats for the development of improved serological tests for the diagnosis, seroepidemiology, and serosurveillance of B. procyonis larva migrans.


We thank Mark Eberhard of the Division of Parasitic Diseases, CDC, for providing serum from the experimentally infected baboon.

This work was supported by multisponsored research grants and gift funds of K. R. Kazacos and voluntary support by the CDC for K. Hancock.


[down-pointing small open triangle]Published ahead of print on 6 October 2010.


1. Blaxter, M. 1998. Caenorhabditis elegans is a nematode. Science 282:2041-2046. [PubMed]
2. Boyce, W. M., B. A. Branstetter, and K. R. Kazacos. 1988a. In vitro culture of Baylisascaris procyonis and initial analysis of larval excretory-secretory antigens. Proc. Helminthol. Soc. Wash. 55:15-18.
3. Boyce, W. M., B. A. Branstetter, and K. R. Kazacos. 1988b. Comparative analysis of larval excretory-secretory antigens of Baylisascaris procyonis, Toxocara canis and Ascaris suum by Western blotting and enzyme immunoassay. Int. J. Parasitol. 18:109-113. [PubMed]
4. Chun, C. S., K. R. Kazacos, C. Glaser, D. Bardo, S. Dangoudoubiyam, and R. Nash. 2009. Global neurological deficits with Baylisascaris encephalitis in a previously healthy teenager. Pediatr. Infect. Dis. J. 28:925-927. [PubMed]
5. Cox, G. N., D. Pratt, R. Hageman, and R. J. Boisvenue. 1990. Molecular cloning and primary sequence of a cysteine protease expressed by Haemonchus contortus adult worms. Mol. Biochem. Parasitol. 41:25-34. [PubMed]
6. Cunningham, C. K., K. R. Kazacos, J. A. McMillan, J. A. Lucas, J. B. McAuley, E. J. Wozniak, and L. B. Weiner. 1994. Diagnosis and management of Baylisascaris procyonis infection in an infant with nonfatal meningoencephalitis. Clin. Infect. Dis. 18:868-872. [PubMed]
7. Dangoudoubiyam, S., and K. R. Kazacos. 2009. Differentiation of larva migrans caused by Baylisascaris procyonis and Toxocara species by Western blotting. Clin. Vaccine Immunol. 16:1563-1568. [PMC free article] [PubMed]
8. Eamsobhana, P., J. Ongrotchanakun, A. Yoolek, P. Punthuprapasa, N. Monkong, and P. Dekumyoy. 2006. Multi-immunodot for rapid differential diagnosis of eosinophilic meningitis due to parasitic infections. J. Helminthol. 80:249-254. [PubMed]
9. Fan, C. K., and K. E. Su. 2004. Cross-reactions with Ascaris suum antigens of sera from mice infected with A. suum, Toxocara canis, and Angiostrongylus cantonensis. Parasitol. Int. 53:263-271. [PubMed]
10. Gems, D., and R. M. Maizels. 1996. An abundantly expressed mucin-like protein from Toxocara canis infective larvae: the precursor of the larval surface coat glycoproteins. Proc. Natl. Acad. Sci. U. S. A. 93:1665-1670. [PubMed]
11. Goldberg, M. A., K. R. Kazacos, W. M. Boyce, E. Ai, and B. Katz. 1993. Diffuse unilateral subacute neuroretinitis. Morphometric, serologic, and epidemiologic support for Baylisascaris as a causative agent. Ophthalmology 100:1695-1701. [PubMed]
12. Gomez-Morales, M. A., A. Ludovisi, M. Amati, S. Cherchi, P. Pezzotti, and E. Pozio. 2008. Validation of an enzyme-linked immunosorbent assay for diagnosis of human trichinellosis. Clin. Vaccine Immunol. 15:1723-1729. [PMC free article] [PubMed]
13. Hajek, J., Y. Yau, P. Kertes, T. Soman, S. Laughlin, R. Kanani, K. R. Kazacos, S. Dangoudoubiyam, and M. A. Opavsky. 2009. A child with raccoon roundworm meningoencephalitis: a pathogen emerging in your own backyard? Can. J. Infect. Dis. Med. Microbiol. 20:e177-e180. [PMC free article] [PubMed]
14. Jacquier, P., B. Gottstein, Y. Stingelin, and J. Eckert. 1991. Immunodiagnosis of toxocarosis in humans: evaluation of a new enzyme-linked immunosorbent assay kit. J. Clin. Microbiol. 29:1831-1835. [PMC free article] [PubMed]
15. Julenius, K., A. Molgaard, R. Gupta, and S. Brunak. 2005. Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 15:153-164. [PubMed]
16. Karanu, F. N., F. R. Rurangirwa, T. C. McGuire, and D. P. Jasmer. 1993. Haemonchus contortus: identification of proteases with diverse characteristics in adult worm excretory-secretory products. Exp. Parasitol. 77:362-371. [PubMed]
17. Kazacos, K. R. 2001. Baylisascaris procyonis and related species, p. 301-341. In W. M. Samuel, M. J. Pybus, and A. A. Kocan (ed.), Parasitic diseases of wild mammals, 2nd ed. Iowa State University Press, Ames, IA.
18. Kazacos, K. R., W. L. Wirtz, P. P. Burger, and C. S. Christmas. 1981. Raccoon ascarid larvae as a cause of fatal central nervous system disease in subhuman primates. J. Am. Vet. Med. Assoc. 179:1089-1094. [PubMed]
19. Kirkland, T. N., F. Finley, K. I. Orsborn, and J. N. Galgiani. 1998. Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice. Infect. Immun. 66:3519-3522. [PMC free article] [PubMed]
20. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685. [PubMed]
21. Lightowlers, M. W., and M. D. Rickard. 1988. Excretory-secretory products of helminth parasites: effects on host immune responses. Parasitology 96(Suppl.):S123-S166. [PubMed]
22. Maizels, R. M., K. K. Tetteh, and A. Loukas. 2000. Toxocara canis: genes expressed by the arrested infective larval stage of a parasitic nematode. Int. J. Parasitol. 30:495-508. [PubMed]
23. Mohamad, S., N. C. Azmi, and R. Noordin. 2009. Development and evaluation of a sensitive and specific assay for diagnosis of human toxocariasis by use of three recombinant antigens (TES-26, TES-30USM, and TES-120). J. Clin. Microbiol. 47:1712-1717. [PMC free article] [PubMed]
24. Murray, W. J., and K. R. Kazacos. 2004. Raccoon roundworm encephalitis. Clin. Infect. Dis. 39:1484-1492. [PubMed]
25. Ozaki, L. S., P. Svec, R. S. Nussenzweig, V. Nussenzweig, and G. N. Godson. 1983. Structure of the Plasmodium knowlesi gene coding for the circumsporozoite protein. Cell 34:815-822. [PubMed]
26. Page, L. K., R. K. Swihart, and K. R. Kazacos. 1999. Implications of raccoon latrines in the epizootiology of baylisascariasis. J. Wildl. Dis. 35:474-480. [PubMed]
27. Pai, P. J., B. G. Blackburn, K. R. Kazacos, R. P. Warrier, and R. E. Bégué. 2007. Full recovery from Baylisascaris procyonis eosinophilic meningitis. Emerg. Infect. Dis. 13:928-930. [PubMed]
28. Romasanta, A., J. L. Romero, M. Arias, R. Sanchez-Andrade, C. Lopez, J. L. Suarez, P. Diaz, P. Diez-Banos, P. Morrondo, and A. Paz-Silva. 2003. Diagnosis of parasitic zoonoses by immunoenzymatic assays—analysis of cross-reactivity among the excretory/secretory antigens of Fasciola hepatica, Toxocara canis, and Ascaris suum. Immunol. Invest. 32:131-142. [PubMed]
29. Rowley, H. A., R. M. Uht, K. R. Kazacos, J. Sakanari, W. V. Wheaton, A. J. Barkovich, and A. W. Bollen. 2000. Radiologic-pathologic findings in raccoon roundworm (Baylisascaris procyonis) encephalitis. Am. J. Neuroradiol. 21:415-420. [PubMed]
30. Sambrook, J., and D. W. Russell. 2001. Screening expression libraries, p. 14.11-14.44, Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
31. Schultz, J., F. Milpetz, P. Bork, and C. P. Ponting. 1998. SMART, a simple modular architecture research tool: identification of signaling domains. Proc. Natl. Acad. Sci. U. S. A. 95:5857-5864. [PubMed]
32. Speiser, F., and B. Gottstein. 1984. A collaborative study on larval excretory/secretory antigens of Toxocara canis for the immunodiagnosis of human toxocariasis with ELISA. Acta Trop. 41:361-372. [PubMed]
33. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:4350-4354. [PubMed]
34. Yamasaki, H., K. Araki, P. K. Lim, N. Zasmy, J. W. Mak, R. Taib, and T. Aoki. 2000. Development of a highly specific recombinant Toxocara canis second-stage larva excretory-secretory antigen for immunodiagnosis of human toxocariasis. J. Clin. Microbiol. 38:1409-1413. [PMC free article] [PubMed]
35. Zhang, Z., S. Schwartz, L. Wagner, and W. Miller. 2000. A greedy algorithm for aligning DNA sequences. J. Comput. Biol. 7:203-214. [PubMed]

Articles from Clinical and Vaccine Immunology : CVI are provided here courtesy of American Society for Microbiology (ASM)